Epidarex Capital Fund IV
Share
N°01 / About
About Epidarex Capital Fund IV
Transatlantic life-science fund secured $145M first close for Fund IV to fuel early-stage drug discovery and healthtech startups in the UK and US.
Investor Signals Profile
active
Sweet Spot
Rare disease biotech founders with clinical validation
27 signals on Epidarex Capital Fund IV
16 bullish · 5 pitch do's · 2 don'ts · 4 GP profiles, each with its source. From €9/month, cancel anytime.